It also diminishes gastrointestinal motility, which contributes to the normalization of blood glucose levels in type II diabetes mellitus after exogenous GLP-1 administration and promotes satiety by ensuing reduction of food intake [44]. Here, GLP1R is linked to type 2 diabetes mellitus.